Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Dana Mikulenkova"'
Publikováno v:
European Journal of Histochemistry, Vol 68, Iss 3 (2024)
The present study was undertaken to provide more information on the peripheral RNA containing ring of ringshaped nucleoli (RSNo). Human lymphocytes of blood donors and patients suffering from B chronic lymphocytic leukemia mostly characterized by RSN
Externí odkaz:
https://doaj.org/article/f249dff696a74e2d89a5565c9353e4af
Autor:
Tomas Stopka, Jiri Zavadil, Arthur I. Skoultchi, Dana Mikulenkova, Petra Basova, Juraj Kokavec, Nikola Curik, Pavel Burda
Supplementary Data from PU.1 Activation Relieves GATA-1–Mediated Repression of Cebpa and Cbfb during Leukemia Differentiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a0dd48882e5556010c90c02a9f8b67
https://doi.org/10.1158/1541-7786.22520710.v1
https://doi.org/10.1158/1541-7786.22520710.v1
Autor:
Tomas Stopka, Jiri Zavadil, Arthur I. Skoultchi, Dana Mikulenkova, Petra Basova, Juraj Kokavec, Nikola Curik, Pavel Burda
Hematopoietic transcription factors GATA-1 and PU.1 bind each other on DNA to block transcriptional programs of undesired lineage during hematopoietic commitment. Murine erythroleukemia (MEL) cells that coexpress GATA-1 and PU.1 are blocked at the bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56a19708f4b79214ed40766a767672af
https://doi.org/10.1158/1541-7786.c.6542737
https://doi.org/10.1158/1541-7786.c.6542737
Autor:
Monika Kaisrlikova, Jitka Vesela, David Kundrat, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Vladimir Divoky, Marek Jedlicka, Jan Fric, Jiri Klema, Dana Mikulenkova, Marketa Stastna Markova, Marie Lauermannova, Jolana Mertova, Jacqueline Soukupova Maaloufova, Anna Jonasova, Jaroslav Cermak, Monika Belickova
Publikováno v:
Leukemia. 36:1898-1906
Patients with lower-risk myelodysplastic syndromes (LR-MDS) have a generally favorable prognosis; however, a small proportion of cases progress rapidly. This study aimed to define molecular biomarkers predictive of LR-MDS progression and to uncover c
Autor:
Jitka Vesela, Hana Votavova, Monika Kaisrlikova, Zuzana Lenertova, David Kundrat, Iva Trsová, Sarka Ransdorfova, Dana Mikulenkova, Jaroslav Cermak, Monika Belickova
Publikováno v:
Blood. 140:4098-4099
Autor:
Monika Belickova, Antonin Vitek, Jacqueline Soukupova, Kyra Michalova, Petr Cetkovsky, Jana Brezinova, Marketa Stastna, Dana Mikulenkova, Veronika Valkova, Jaroslav Cermak
Publikováno v:
Blood. 132:4372-4372
AIM OF THE STUDY, PATIENTS AND METHODS : The data obtained from a long-term follow-up for a period of 30 years (1988-2017) were analyzed in a group of 529 patients with primary MDS and factors affecting prolonged survival were detected using differen
Autor:
Denisa Myslivcova, Jaroslav Cermak, Dana Mikulenkova, Cyril Šálek, Jana Brezinova, Marie Lauermannova, Radka Bokorova, Kyra Michalova, Ota Fuchs, Anna Jonasova, Jaroslav Polák, Zuzana Zemanova, R. Neuwirtova, Marketa Stastna
Publikováno v:
Blood. 132:5507-5507
INTRODUCTION Nrf2 (nuclear factor, erythroid-derived 2-like 2 or NF-E2-related factor 2) is a transcription factor involved in antioxidant response by reducing oxidative stress. Erythropoietin (EPO) was described as an inducer of Nrf2 in the brain. N
Autor:
Tomas Stopka, Juraj Kokavec, Petra Basova, Pavel Burda, Dana Mikulenkova, Nikola Curik, Jiri Zavadil, Arthur I. Skoultchi
Publikováno v:
Molecular Cancer Research. 7:1693-1703
Hematopoietic transcription factors GATA-1 and PU.1 bind each other on DNA to block transcriptional programs of undesired lineage during hematopoietic commitment. Murine erythroleukemia (MEL) cells that coexpress GATA-1 and PU.1 are blocked at the bl
Autor:
D. Myslivcova, Dana Mikulenkova, J. Soukupova Maaloufova, Anna Jonasova, R. Neuwirtova, Tomas Stopka, Arnost Kostecka, R. Bokorova, M. Siskova, M. Lauermannova, Cyril Šálek, Kyra Michalova, Jana Brezinova, Jaroslav Cermak, M. Vostry, Jaroslav Polák, Zuzana Zemanova, Ota Fuchs
Publikováno v:
ResearcherID
Autor:
Kyra Michalova, Monika Belickova, B. Planetova, J. Vesela, Jana Brezinova, Zuzana Zemanova, Anna Jonasova, Dana Mikulenkova, Jaroslav Cermak, J. Valka
Publikováno v:
Leukemia Research. 39:S22-S23